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MaOBJECTIVES This study sought to evaluate the diagnostic yield of triple rule out (TRO) versus coronary computed
tomography angiography (CTA) scanning in patients with acute chest pain enrolled in a large statewide registry.
BACKGROUND Although TRO scans provide simultaneous evaluation of coronary artery disease (CAD), pulmonary
embolism (PE), and aortic disease (AD), their use is not well deﬁned.
METHODS Patients undergoing TRO or coronary CTA at 53 Michigan institutions for acute chest pain (in the emergency
department or inpatient setting) in the ACIC (Advanced Cardiovascular Imaging Consortium) were included. Demographic
characteristics, scan ﬁndings, and image quality parameters were compared between coronary CTA and TRO scans. The
primary outcome was diagnostic yield, deﬁned as obstructive CAD (>50% stenosis), PE, or AD; secondary outcomes were
radiation dose, contrast volume, and image quality.
RESULTS From July 2007 to September 2013, 12,834 patients underwent computed tomography scanning (TRO,
n ¼ 1,555; coronary CTA, n ¼ 11,279). The TRO group had more women (57.1% vs. 47.8%, p < 0.001). Diagnostic yield
was similar (TRO, 17.4% vs. coronary CTA, 18.3%; p ¼ 0.37), driven by CAD (15.5% vs. 17.2%, p ¼ 0.093); PE and AD
were 1.1% and 0.4% (p ¼ 0.004) and 1.7% and 1.1% (p ¼ 0.046). TRO had higher median radiation (9.1 mSv vs. 6.2 mSv;
p < 0.0001) and mean contrast (113  6 ml vs. 89  17 ml; p < 0.0001) doses. Nondiagnostic images were frequent in
TRO (9.4% vs. 6.5%; p < 0.0001). In emergency department patients, PE and AD were more often detected on TRO.
Among inpatients, there were no differences in overall yield or in that of PE, AD, or CAD.
CONCLUSIONS TRO was associated with slightly higher yield of PE and AD, speciﬁcally in the emergency department.
This beneﬁt comes with higher nondiagnostic image quality, radiation, and contrast doses. Although TRO may be of
value in selected patients, its indiscriminate use is not warranted. The appropriate use of TRO needs to be further
deﬁned. (Advanced Cardiovascular Imaging Consortium [ACIC]; NCT00640068) (J Am Coll Cardiol Img 2015;8:817–25)
© 2015 by the American College of Cardiology Foundation.A nnually, more than 5.5 million patientspresent to emergency departments (EDs)throughout the United States with acute
noninjury-related chest pain, the majority of whom
are discharged with a diagnosis other than acute
coronary syndrome (1,2). Despite this, there has
been a dramatic increase in advanced imaging form the Department of Cardiovascular Medicine, William Beaumont Hospi
d funded by the Blue Cross/Blue Shield/Blue Care network of Michig
orted that they have no relationships relevant to the contents of this pap
nuscript received October 14, 2014; revised manuscript received Februaracute chest pain totaling more than $10 billion annu-
ally (1,3).
Although subjective and objective data assist in the
evaluation of acute chest pain, patient history has
proved unreliable (4). Care providers focus much of
their efforts on the evaluation of obstructive coronary
artery disease (CAD), pulmonary embolism (PE), andtal, Royal Oak, Michigan. This study was sponsored
an (BCBSM), Detroit, Michigan. The authors have
er to disclose.
y 10, 2015, accepted February 12, 2015.
TABLE 1 Sample Protocols (on
Coron
Scan range Start: Just below
End: Inferior bord
Scan direction Craniocaudal
Gantry angle No angle
Scan mode* High-pitch, adapt
or spiral with
(0.6-mm dete
0.28 s rotation
Field of view 150–200 mm
Contrast Iopamidol (Isovue
Diagnostics In
Township, Ne
60 ml at 5.5–
saline ﬂush
Procedure Care bolus at asc
triggered at 9
Reconstruction
algorithm
Filtered back pro
reconstruction
habitus
*Tube voltage is determined by body ma
AD ¼ aortic dissection; CTA ¼ comput
embolism; TRO ¼ triple rule out.
ABBR EV I A T I ON S
AND ACRONYMS
AD = aortic dissection
CAD = coronary artery disease
CTA = computed tomography
angiography
ED = emergency department
PE = pulmonary embolism
TRO = triple rule out
Burris et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 7 , 2 0 1 5
Coronary CTA and Triple Rule Out Diagnostic Yield J U L Y 2 0 1 5 : 8 1 7 – 2 5
818aortic dissection (AD) (2). When left undiag-
nosed, these are associated with increased
mortality, poor prognosis, and malpractice
litigation (5,6).
In the evaluation of acute chest pain with
low to intermediate risk of acute coronary
syndrome, coronary computed tomography
angiography (CTA) provides a time- and cost-
efﬁcient option in the evaluation of obstruc-
tive CAD, with a negative predictive value ofnearly 100% (7–9). In addition to its diagnostic role in
evaluating chest pain, the prognostic utility of coro-
nary CTA is increasingly being established (10,11).
Despite its improved diagnostic efﬁciency over tradi-
tional acute chest pain evaluation protocols, coronary
CTA allows only a limited assessment of the pulmo-
nary vasculature and aortic arch.SEE PAGE 826A triple rule out (TRO) coronary CTA protocol has
thus been implemented (12,13). This protocol allowsa Dual-Source, High-Pitch Capable Scanner)
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ss index and body habitus. All patients were positioned supine head ﬁrst.
ed tomography angiography; ECG ¼ electrocardiogram; PE ¼ pulmonaryfor simultaneous assessment of the thorax for CAD,
PE, and AD with similar diagnostic yield, median
hospital length of stay, and cost of care as with
traditional coronary CTA protocols (14,15). Although
image quality has been shown to be equivalent, this
often comes at the cost of increased contrast volume
and radiation exposure (14–16).
This study was performed to compare the diag-
nostic yield of traditional CTA and TRO protocols in
the evaluation of acute chest pain across a variety of
medical centers participating in the ACIC (Advanced
Cardiovascular Imaging Consortium).
METHODS
STUDY POPULATION. The ACIC was a statewide
quality improvement initiative sponsored by Blue
Cross Blue Shield/Blue Care Network of Michigan and
included 53 hospitals and imaging centers performing
coronary CTA (17). Participating centers received in-
ternal review board approval and included a waiver of
consent. The ACIC database includes demographic
characteristics, risk factors, symptoms, results of pre-
vious testing, and medical history. To ensure data
accuracy, patients were interviewed at the point-of-
service for symptoms and medical history. Pre-test
likelihood of CAD is calculated using the Diamond-
Forrester criteria. Nurses and/or technologists recor-
ded information aboutmedication use, vital signs, and
procedural times. Information was also provided
about the scanner model and manufacturer and
protocol parameters. Effective radiation exposure and
intravenous contrast doses were recorded. Coronary
artery calcium scoring scans were performed only
when speciﬁcally requested by the ordering physician.
Patients undergoing computed tomography (CT)
scanning in the ED or as inpatients at these centers
from 2007 to 2013 were included in this analysis.
Outpatient studies were excluded.
CORONARY CTA PROTOCOL AND IMAGE
INTERPRETAT ION . Coronary CTA was performed
on various types of scanners available at each insti-
tution, ranging from 64- to 320-slice scanners, with
scan techniques dictated by standard clinical pro-
tocols at each site (18). Multiple manufacturers
(Siemens Healthcare [Erlangen, Germany], Philips
Medical Systems [Eindhoven, the Netherlands], GE
Healthcare [Milwaukee, Wisconsin], and Toshiba
Medical Systems [Otawara, Japan]) with single- or
dual-source systems were used. Beta-blockers were
typically administered before scanning with a target
heart rate as close to 60 beats/min as possible. Sub-
lingual nitroglycerin was also given before scanning
to patients who had no contraindication. Typical tube
TABLE 2 Patient Characteristics
Coronary CTA
(n ¼ 11,279)
TRO
(n ¼ 1,555) p Value
Age, yrs 52  13 (51) 53  13 (52) 0.027
Women 5,380 (47.8) 888 (57.1) <0.0001
Body mass index, kg/m2 30  6.3 (29) 30  6.1 (29) 0.73
Body mass index >30 kg/m2 4,490 (39.9) 635 (40.8) 0.49
Family history of premature CAD 3,933/10,576 (37.2) 466/1,468 (31.7) <0.0001
Diabetes 1,500 (13.4) 194 (12.5) 0.36
Hypertension 5,220 (46.8) 767 (49.9) 0.022
Hyperlipidemia 4,907/10,617 (46.2) 625/1,445 (43.3) 0.034
History of CAD 1,784 (15.8) 215 (13.8) 0.042
Previous MI 890 (8.0) 82 (5.3) 0.0002
Previous PCI 676 (6.1) 75 (4.9) 0.062
Coronary artery bypass grafting 466 (4.2) 63 (4.1) 0.86
Smoker <0.0001
Never 5,749 (51.2) 889 (57.5)
Former (>12 months) 2,633 (23.4) 345 (22.3)
Recent (within 12 months) 276 (2.5) 30 (1.9)
Current 2,575 (22.9) 283 (18.3)
Congestive heart failure 517 (4.7) 36 (2.3) <0.0001
Cardiac arrest 174/11,040 (1.6) 6/1,518 (0.4) 0.0003
Atrial ﬁbrillation 671/11,042 (6.1) 66/1,532 (4.3) 0.006
Peripheral vascular disease 298/10,909 (2.7) 22/1,511 (1.5) 0.003
Cerebrovascular accident 532/11,102 (4.8) 54/1,532 (3.5) 0.027
Chronic obstructive lung disease 1,220/11,114 (11) 159/1,534 (10.4) 0.47
Valvular heart disease 834/10,878 (7.7) 133/1,512 (8.8) 0.13
Chronic kidney disease 137 (1.2) 11 (0.7) 0.08
Patient status ¼ ED versus inpatient 7,070 (63.0) 1,158 (74.5) <0.0001
Chest pain risk (Diamond-Forrester
criteria), n
10,583 1,503 <0.0001
Very low 397 (3.8) 71 (4.7)
Low 906 (8.6) 170 (11.3)
Intermediate 6,654 (62.9) 994 (66.1)
High 2,626 (24.8) 268 (17.8)
Framingham Risk Score, n 11,226 1,547 0.76
Low 7,292 (65.0) 990 (64.0)
Intermediate 2,642 (23.5) 375 (24.2)
High 1,292 (11.5) 182 (11.8)
Values are mean  SD (median), n (%), or n/N (%).
CAD ¼ coronary artery disease; ED ¼ emergency department; MI ¼ myocardial infarction; PCI ¼ percutaneous
coronary intervention; other abbreviations as in Table 1.
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819voltage was based on body mass index typically
ranging from 100 to 120 kV, but as low as 80 kV on
selected scans. Both prospective and retrospective
scanning protocols were used (Table 1). Prospective
includes both axial or “step-and-shoot” scanning and
high-pitch spiral scanning. Topograms were obtained
to determine scan range. Tube current, gantry rota-
tion time, pitch, and collimation varied based on the
protocol and manufacturer. Iodinated contrast
infused during the scan varied based on scan length
and time, patient habitus, and cardiac output. Details
of bolus tracking/timing or number of contrast bolus
phases were not speciﬁed. Protocols were generally
determined based on the reading physician’s discre-
tion; there were no pre-speciﬁed parameters across
centers with regard to heart rate, arrhythmia, body
habitus and other patient-related factors.
Coronary CTA scans were interpreted at each insti-
tution by cardiologists and/or radiologists with Level
II (or III) training. Coronary stenoses were evaluated
using a 16-segment model. Obstructive CAD was
deﬁned as coronary stenosis >50% in major epicardial
vessels (left main, proximal, and mid segments of the
left anterior descending, left circumﬂex, and right
coronary arteries and the ﬁrst and second diagonal
and obtuse marginal branches). At centers where a
cardiologist was the primary reader, all studies were
read by a radiologist for noncardiac pathology.
IMAGE QUALITY. The quality of each study was rated
by the reading physician at every site on a scale of
1 to 4. Excellent (a score of 1) was deﬁned as complete
absence of motion artifacts, excellent signal-to-noise
ratio, and clear delineation of vessel walls, with the
ability to assess luminal stenosis as well as plaque
characteristics. Good (a score of 2) was deﬁned as
nonlimiting motion artifacts, reduced signal-to-noise
ratio, and/or calciﬁcations present, with preserved
ability to assess luminal stenosis as well as plaque
characteristics. Adequate (a score of 3) was deﬁned as
reduced image quality due to any combination of
noise, motion, poor contrast enhancement, or cal-
cium that signiﬁcantly impairs ease of interpretation,
but image quality is sufﬁcient to rule out signiﬁcant
stenosis. Nondiagnostic (a score of 4) was deﬁned as
reduced image quality that precludes adequate
assessment of stenosis in the majority of vessels (18).
Individual readers based their rating on clinical
impression; sample images were not provided.
ESTIMATION OF RADIATION DOSE. Radiation doses
were estimated by previously described methods
(19,20). Each scanner provided a protocol summary
containing the dose/length product for each image
series, which integrated estimated absorbed radiationin the x, y, and z directions based on the CT dose index
volume. The total dose for the entire CT examination
was then used to derive the effective radiation dose
using the summed dose/length product multiplied by
the European Working Group for Guidelines on Qual-
ity Criteria in Computed Tomography conversion co-
efﬁcient (kappa ¼ 0.014 mSv/mGy$cm) (21).
STUDY ENDPOINTS. The primary endpoint of this
study was diagnostic yield: a composite of coronary
artery diameter stenosis >50%, PE, and AD. The
threshold of 50% luminal narrowing was used because
this often prompts further invasive or noninvasive
coronary evaluation. Secondary endpoints included
radiation dose, contrast volume, and image quality.
TABLE 3 Findings on Coronary CTA Examination
All Patients
Coronary CTA
(n ¼ 11,279)
TRO
(n ¼ 1,555) p Value
AD 129 (1.1) 27 (1.7) 0.046
PE 47 (0.4) 17 (1.1) 0.0004
CT stenosis >50%* 1,932 (17.2) 239 (15.5) 0.093
Diagnostic yield (any of the 3 above) 2,065 (18.3) 270 (17.4) 0.37
Uninterpretable CTA scan 725 (6.5) 145 (9.4) <0.0001
Male Patients Only (n ¼ 5,886) (n ¼ 667)
AD 82 (1.4) 15 (2.3) 0.083
PE 24 (0.4) 9 (1.4) 0.005
CT stenosis >50%* 1,205/5,875 (20.5) 151/663 (22.8) 0.17
Diagnostic yield (any of the 3 above) 1,286 (21.9) 168 (25.2) 0.049
Uninterpretable CTA scan 358/5,866 (6.1) 51/658 (7.8) 0.098
Female Patients Only (n ¼ 5,380) (n ¼ 888)
AD 47 (0.9) 12 (1.4) 0.17
PE 23 (0.4) 8 (0.9) 0.071
CT stenosis >50%* 726/5,367 (13.5) 88/883 (10.0) 0.004
Diagnostic yield (any of the 3 above) 778 (14.5) 102 (11.5) 0.018
Uninterpretable CTA scan 364/5,362 (6.8) 94/886 (10.6) <0.0001
Centers Performing Both Coronary
CTA and TRO Only (n ¼ 10,419) (n ¼ 1,555)
CT ﬁndings: AD 119 (1.1) 27 (1.7) 0.046
CT ﬁndings: PE 40 (0.4) 17 (1.1) 0.0002
CT stenosis >50%* 1,774 (17.1) 239 (15.5) 0.12
Diagnostic yield (any of the 3 above) 1,896 (18.2) 270 (17.4) 0.43
Uninterpretable CTA scan 649 (6.3) 145 (9.4) <0.0001
Emergency Department Patients Only (n ¼ 7,070) (n ¼ 1,158)
CT ﬁndings: AD 64 (0.9) 21 (1.8) 0.0046
CT ﬁndings: PE 7 (0.1) 11 (1.0) <0.0001
CT stenosis >50%* 830 (11.8) 134 (11.6) 0.91
Diagnostic yield (any of the 3 above) 888 (12.6) 158 (13.6) 0.30
Uninterpretable CTA scan 403/7,060 (5.7) 95/1,152 (8.3) 0.0008
Inpatients Only (n ¼ 4,162) (n ¼ 396) p Value
CT ﬁndings: AD 65 (1.6) 6 (1.5) 0.94
CT ﬁndings: PE 39 (0.9%) 6 (1.5%) 0.28
CT stenosis >50%* 1,090/4,147 (26.3) 105/393 (26.7) 0.85
Diagnostic yield (any of the 3 above) 1,165 (28.0) 112 (28.3) 0.90
Uninterpretable CTA scan 318/4137 (7.7) 50/391 (12.8) 0.0004
Values are n (%) or n/N (%). *Greater than 50% stenosis in a major epicardial vessel (left main, proximal, and mid
segments of the left anterior descending, left circumﬂex, and right coronary arteries and ﬁrst and second di-
agonal and obtuse marginal branches).
CT ¼ computed tomography; other abbreviations as in Table 1.
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820STATISTICAL ANALYSIS. All statistical analyses were
performed using version 9.3 of SAS for Windows (SAS
Institute, Cary, North Carolina). The study population
was divided into 2 groups based on the protocol:
1) coronary CTA; and 2) TRO. Using Pearson’s chi-
square where the expected frequency was >5 or
the Fisher exact test, the categorical variables were
reported as numbers and percentages. Continuous
variables were examined using logistic regression,
with TRO as the dependent variable and reportedas mean  SD or median and 25th, 75th percentiles
where appropriate. Backward elimination logistic
regression analysis was performed to determine
whether TRO was an independent predictor of diag-
nostic yield as well as to determine predictors of un-
interpretable scans. The following signiﬁcant variables
were included: sex, age, body mass index >30 kg/m2,
Framingham Risk Score, scanning mode, tube
strength, radiation dose (mSv), heart rate (beats/min),
contrast volume (ml), and history of atrial ﬁbrillation,
valve disease, chronic obstructive lung disease, or
congestive heart failure.
RESULTS
BASELINE CHARACTERISTICS. A total of 12,834
patients from July 2007 to September 2013 at 53
institutions in Michigan met the study criteria. Of
these, 11,279 (87.9%) were in the coronary CTA
group and 1,555 (12.1%) were in the TRO group.
Demographic characteristics were similar in both
groups (Table 2). Those undergoing TRO were more
often women (57.1% vs. 47.8%; p < 0.0001) with a
lower CAD pre-test likelihood according to the
Diamond-Forrester criteria and a lower frequency
of tobacco use, family history of premature CAD,
hypertension, and hyperlipidemia.
PRIMARY OUTCOME. Composite diagnostic yield
determined by the presence of obstructive CAD
(stenosis >50%), PE, and/or AD was 17.4% for TRO and
18.3% for coronary CTA (p ¼ 0.37) (Table 3). This was
driven by obstructive CAD: 15.5% in TRO and 17.2% in
coronary CTA (p ¼ 0.93) and accounted for 88.5% and
93.6% of diagnoses, respectively. Diagnostic yields of
PE and AD were 1.1% and 0.4% (p ¼ 0.0004) and 1.7%
and 1.1% (p ¼ 0.046), respectively. Some patients had
more than 1 diagnosis. A multivariable model for
diagnostic yield adjusting for the differences between
the TRO and coronary CTA subjects found that having
a TRO scan was not predictive (odds ratio: 0.87, 95%
conﬁdence interval: 0.71 to 1.07) of diagnostic yield.
PE and AD were diagnosed more often on TRO
than on coronary CTA in centers that routinely per-
formed TRO and coronary CTA, with no statistically
signiﬁcant difference in the overall diagnostic yield.
Uninterpretable studies were more often reported
with TRO than with coronary CTA. Similarly, PE and
ADwere more often detected on TRO than on coronary
CTA among ED patients. Among inpatients, however,
there was no difference in the detection of PE and
AD between TRO and coronary CTA (Table 3).
SECONDARY OUTCOMES. The median radiation
dose was 49% higher for TRO than CTA: 9.1 mSv
(interquartile range: 6.4 to 13.5) versus 6.2 mSv
TABLE 5 Reasons for Poor/Uninterpretable Image Quality
Non–TRO
(n ¼ 725)
TRO
(n ¼ 145) p Value
Calcium 173/709 (24.4) 27/140 (19.3) 0.19
Motion 486/714 (68.1) 96/142 (67.6) 0.91
Noisy image 203/714 (28.4) 42/142 (29.6) 0.78
Low vascular contrast 192/711 (27.0) 37/143 (25.9) 0.78
Values are n/N (%).
Abbreviations as in Table 1.
TABLE 4 Speciﬁcs of CTA TRO Examination
Coronary CTA
(n ¼ 11,279)
TRO
(n ¼ 1,555) p Value
Scanner type, n 11,256 1,554 <0.0001
64-slice 3,793 (33.7) 54 (3.5)
Dual source 2,528 (22.5) 607 (39.1)
320 35 (0.3) 1 (0.06)
High-pitch spiral 4,900 (43.5) 892 (57.4)
Pre-scan heart rate–lowering
medications
9,276 (82.5) 1,292 (83.3) 0.43
Average heart rate during scan 60  8.4 (59) 62  8.8 (61) <0.0001
Pre-scan sublingual nitroglycerin 10,414 (92.5) 1,512 (97.2) <0.0001
Contrast volume 89  17 (85) 113  16 (120) <0.0001
Scan length 13.2  2.1 (14) 16.8  2.6 (17) <0.0001
Tube potential, kV 111  11 (120) 112  10 (120) 0.18
ECG dose modulation 8,616 (76.8) 1,019 (65.7) <0.0001
Total dose/length product 442 (276, 826) 651 (458, 962) <0.0001
Effective radiation dose, mSv 6.2 (3.9, 11.6) 9.1 (6.4, 13.5) <0.0001
CTA scan quality, n 11,237 1,544 0.0001
Excellent 4,344 (38.7) 600 (38.9)
Good 4,492 (40.0) 570 (36.9)
Adequate 1,676 (14.9) 229 (14.8)
Poor/uninterpretable 725 (6.5) 145 (9.4)
Values are n (%), mean  SD (median), or median (25th, 75th).
Abbreviations as in Table 1.
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821(interquartile range: 3.9 to 11.6) (p < 0.0001) (Table 4).
For TRO, themedian dose varied based on protocol and
type of scanner; the lowest radiation dose was associ-
ated with high-pitch spiral scanning. Mean contrast
volumewas 27% higher for TRO than for coronary CTA:
113  16 ml versus 89  17 ml (p < 0.0001). Non-
diagnostic or uninterpretable image quality was noted
more frequently in TRO (9.4% vs. 6.5%; p < 0.0001)
with similar reported reasons (Table 5). Results of the
multivariable model found that the factors that
contributed to poor image quality were higher heart
rates, body mass index >30 kg/m2, valvular heart dis-
ease, congestive heart failure, higher contrast volume,
and higher Framingham Risk Score (Table 6).
DISCUSSION
In this statewide study, the overall diagnostic yield
was similar between TRO and coronary CTA. TRO was
associated with a slightly higher yield of PE and AD,
but also with higher nondiagnostic image quality and
radiation and contrast doses. These data suggest that
although TRO is feasible, it cannot be recommended
in all patients presenting with acute chest symptoms.
Clinical scenarios with the suggestion of increased
risk of PE and/or AD in addition to CAD may present
the best use for TRO.
Although the composite diagnostic yield in both
groups were comparable, this was predominantly
driven by obstructive CAD, which was 15 times that of
PE and AD. Although PE and AD were infrequent, they
were diagnosed more frequently in the TRO group,
unlike a similar study comprising a smaller cohort of
patients with similar risk proﬁles (14). It is important
to note that in that previous study, there was a lower
diagnostic yield for PE in the coronary CTA group
(1.1% with TRO and 0.2% with coronary CTA;
p ¼ 0.05) with no AD in either group. Given similar
patient risk factor proﬁles in the present study, these
differences were most likely driven by sample size as
well as varied protocols across centers. The diagnostic
yield for PE in this study in TRO and coronary CTA
was much lower than the 9% to 19% in dedicated PE
protocols (22–24). However, in those studies, patients
were selected for CT examinations based on clinical
presentation and/or traditional risk stratiﬁcation
models. Although the beneﬁts of risk stratiﬁcation
for PE with D-dimer, Wells criteria, and Geneva
criteria are well described (25,26), their effects on
the diagnostic yield of coronary CT (CTA or TRO)
are yet to be demonstrated. The standardized use of
risk stratiﬁcation tools would likely improve the
diagnostic yield and thus prevent unnecessary use
of TRO.It is important to note that even though the
rates of PE and AD on coronary CTA (with limited ﬁeld
of view) were lower than in dedicated protocols,
they were high for unsuspected but clinically
important diagnoses. However, >97% of TRO studies
showed neither AD nor PE. These discordant ﬁndings
between scan intention and results highlight the fact
that the diagnosis of acute chest pain can be chal-
lenging, particularly because clinical presentations
are often atypical or unclear.
The majority of the overall studies (64%) were
performed in the ED. There was a statistically signif-
icant difference in the diagnostic yield of both PE and
AD with TRO in the ED, but not among inpatients.
This could reﬂect alternate indications for ordering
the study as an inpatient (for example, further
TABLE 6 Multivariate Analysis of Nondiagnostic/Uninterpretable
Image Quality
Odds Ratio 95% CI p Value
Average heart rate during scan
(increments of 10 beats/min)
2.013 1.858–2.181 <0.0001
Body mass index >30 kg/m2 1.744 1.501–2.026 <0.0001
Valvular heart disease 1.467 1.158–1.857 0.0015
Congestive heart failure 1.415 1.048–1.910 0.0233
Contrast volume (every 25 ml) 1.269 1.148–1.403 <0.0001
Framingham Risk Score
(increments of risk categories)
1.221 1.102–1.353 0.0001
TRO scanning 1.018 0.817–1.270 0.8717
ECG dose modulation 0.672 0.572–0.789 <0.0001
CI ¼ conﬁdence interval; other abbreviations as in Table 1.
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822evaluation of an equivocal stress test in the ED or
clariﬁcation of an abnormal chest x-ray).
TRO was associated with higher median radiation
doses and contrast volumes. Although the increased
scan time and scan length required with TRO proto-
cols are generally considered the main cause of an
increased dose, the difference in scan length between
coronary CTA and TRO in this study was only 3.6 cm.
These data suggest “overscanning” on coronary CTA
or “underscanning” on TRO at least at some sites;
with rigid adherence to prescribed scan lengths, the
difference in radiation dose could be conceivably
higher. These data also demonstrate the overall
ordering patterns of both protocols. Patients with
higher pre-test likelihood of CAD underwent coro-
nary CTA, whereas those with a lower likelihood un-
derwent TRO. Thus, TRO included younger patients
and more women, the speciﬁc populations in which
radiation dose exposure must be limited (27). Addi-
tionally, the diagnostic yield among women was one-
half of that in men. This ﬁnding highlights the fact
that women more often present with atypical symp-
toms, but also received unnecessary radiation and
contrast. Although the diagnosis of PE on TRO in the
women who had the disease is a positive, the lack of
such diagnoses in the majority of those scanned
highlight the challenges and limitations of pre-test
clinical identiﬁcation of patients with potential life-
threatening conditions.
There have been extensive, successful efforts by
the ACIC to optimize protocols to decrease radiation
dose (28). Our median radiation dose reﬂects both
older and newer protocols. Most of the scans included
in this study were performed using 64-slice scanners.
Centers using dual-source scanners capable of
high-pitch scanning reported <50% of the median
radiation dose. Also, low-dose protocols for 320-
row scanners can decrease radiation exposureto <3.5 mSv and total contrast volume to 60 ml with-
out sacriﬁcing image quality (29).
TRO was associated with a 45% higher frequency
of nondiagnostic image quality compared with cor-
onary CTA. Although the TRO scan type itself was
not a signiﬁcant predictor of nondiagnostic image
quality on multivariate analysis, it is likely that this
protocol is affected by the type of contrast bolus
used as well as body habitus. Higher heart rates and
ectopy (resulting in motion artifacts) and clinical
conditions that may result in the patient’s inability
to lie ﬂat were found to be signiﬁcant predictive
factors for scan uninterpretability. These results
further demonstrate the need for appropriate patient
selection for TRO to avoid unnecessary radiation
exposure from a nondiagnostic scan, leading to
additional testing with their associated risks and
costs.
CLINICAL IMPLICATIONS. This large multicenter
study suggests that TRO provides a slightly increased
diagnostic yield for PE and AD compared with coro-
nary CTA. It is unclear whether this is related to liberal
use of TRO. Nonetheless, patients undergoing TRO are
more often low-risk women with an overall low yield
on CT scanning. Thus, these results do not necessarily
tip the balance in favor of TRO use in all patients with
acute chest symptoms.
Currently, there are no established guidelines
outlining pre-scan evaluation of indications for
TRO. The effects of clinical evaluation and subse-
quent patient selection on diagnostic yield are un-
known. The results of this study suggest that
although there is a potential utility for TRO in the
evaluation of acute chest pain, appropriate patient
selection through established clinical algorithms is
necessary. TRO must be used judiciously and not
indiscriminately, particularly because nearly 1 in 10
TRO scans was nondiagnostic despite the higher
radiation and contrast doses necessarily associated
with it. TRO may be considered when clinical fea-
tures and initial laboratory data (e.g., indeterminate
troponin and elevated D-dimer) raise concern for: 1)
obstructive CAD; and 2) PE or AD. Therefore, we
propose an algorithm that divides patients present-
ing with acute symptoms into 3 risk groups: high,
low to intermediate, and very low (noncardiac)
(Figure 1). Both coronary CTA and TRO are best
avoided in patients with known CAD; such patients
may be best suited for stress testing with/without
imaging.
Among low- to intermediate-risk patients, clinical
suspicion of PE must warrant additional evaluation of
risk that includes the Wells criteria or Geneva criteria
(e.g., history of deep vein thrombosis, malignancy,
FIGURE 1 Suggested Algorithm for the Use of TRO in Patients With Acute Chest Pain
Coronary CTA
Suggested pathway incorporating the use of TRO protocols in patients with acute chest pain. *Excludes patients with known CAD. ACS ¼ acute coronary syndrome; AD ¼
aortic dissection; CAD ¼ coronary artery disease; CTA ¼ computed tomography angiography; ECG ¼ electrocardiogram; PE ¼ pulmonary embolism; TRO ¼ triple rule out.
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823tachycardia, immobilization, age older than 65 years)
and suggestive laboratory data (increased D-dimer)
(25,26). If the suspicion of PE remains intermediate
with such detailed evaluation along with that for
CAD, TRO may be considered after meticulous patient
preparation (Figure 2).
Similarly, intermediate suspicion of AD (1 high-risk
feature in history, symptoms, or physical examina-
tion) along with continued suspicion of CAD may
warrant TRO (Figure 3). A double rule out protocol
may be considered in patients with an overlap in
diagnosis of AD and CAD with inclusion of the
abdominal aorta, without the extra contrast for opa-
ciﬁcation of the pulmonary circulation. More than 1
high-risk feature in the patient’s history (Marfan syn-
drome, aortic valve disease or recent aortic surgery,known aortic aneurysm), symptoms (abrupt onset of
ripping/tearing/stabbing chest pain), and physical
examination (pulse deﬁcit, blood pressure difference
in limbs, perfusion deﬁcits, murmur of aortic insufﬁ-
ciency) would warrant triage to dedicated AD pathway
for diagnosis and management (30).
STUDY LIMITATIONS. The most important limitation
of this study is its inability to distinguish the source
of the increased diagnostic yield of TRO for PE and
AD. There are 2 possibilities: 1) physicians appropri-
ately selected patients for TRO, yielding a higher
incidence of PE or AD; or 2) the TRO procedure has a
higher sensitivity due to a contrast bolus appropri-
ately timed for right-sided circulation. We were able
to retrospectively evaluate 8 of 17 patients in the TRO
group who had PE and found that each had ﬁlling
FIGURE 3 Aortic Dissection Noted on a TRO Scan
TRO scan in a 52-year-old man with long-standing hypertension
presenting to the emergency department with acute chest pain
radiating to the back. TRO scan reveals aortic dissection (arrows).
TRO ¼ triple rule out.
FIGURE 2 Pulmonary Emboli Noted on a TRO Scan
Triple rule out scan in a 59-year-old woman who presented to
the emergency department with chest pressure, palpitations, and
shortness of breath 1 week after lumbar stenosis surgery. Coro-
nary arteries and aorta were normal on TRO, but she was found
to have extensive bilateral pulmonary emboli with signiﬁcant
ﬁlling defects involving bilateral multiple segmental branches
(arrows). TRO ¼ triple rule out.
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824defects that fell within the imaging window of stan-
dard coronary CTA. However, it is foreseeable that PE
may have been missed on coronary CTA scans due to
a limited ﬁeld of view and/or varying protocols.
As a retrospective study, it is difﬁcult to make
deﬁnitive comparative conclusions. There are multi-
ple participating centers using varied chest pain and
imaging algorithms; thus, this study reﬂects varied
practice patterns. Protocols and physician threshold
for ordering coronary CTA vary within and across
different institutions, with the potential for selection
bias. It is important to note that TRO can often be
used inappropriately as a screening tool to evaluate
all chest pain. Data on varying reconstruction
methods that could have contributed to image quality
were not collected. There is no discrimination of
studies duplicated from patients receiving care at
multiple medical centers.
CONCLUSIONS
In this large registry, TRO was associated with slightly
higher diagnostic yield for PE and AD compared with
coronary CTA, particularly in the ED, and was used
more often in younger women. Additionally, TRO is
associated with signiﬁcantly higher radiation and
contrast doses compared with coronary CTA. Thus,
although feasible, clinical criteria for TRO use and
appropriateness must be further deﬁned.
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COMPETENCY IN PATIENT CARE AND
PROCEDURAL SKILLS: In patients with a low to
intermediate likelihood of CAD and PE/AD, TRO may
result in higher diagnostic yield compared with coro-
nary CTA. Due to the signiﬁcantly higher radiation and
contrast doses associated with TRO, it must be judi-
ciously applied in clinical practice.
TRANSLATIONAL OUTLOOK: Although the diag-
nostic yield for PE and AD was higher in TRO
compared with coronary CTA, it is associated with
higher radiation and contrast doses as well as more
frequent nondiagnostic image quality. Thus, patient
selection and appropriate use of TRO must be further
deﬁned.
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